November 8th 2022
This digital series explores the evolving first-line treatment landscape of advanced or metastatic solid tumors, including non-small cell lung cancer, with an emphasis on the use of immune checkpoint inhibitors alone or in combination with other treatment modalities.
August 5th 2022
This digital series highlights the mechanistic rationale behind use of tumor-infiltrating lymphocytes in solid tumors, including NSCLC, and addresses the possible challenges and benefits of this treatment approach.
August 2nd 2022
This series explores the development and clinical utility of CAR T-cell therapy in treating patients with mantle cell lymphoma.
December 23rd 2021
This series explores new developments in the molecular pathology and management of NTRK fusion-positive cancers.
September 20th 2021
This digital series raises awareness regarding the challenges in treating extensive-stage small cell lung cancer through a review of the current treatment landscape, recently approved therapeutics, and emerging options for addressing the consequences of treatment.
August 30th 2021
This digital series raises awareness regarding the evolving spectrum of precision medicine in advanced prostate cancer through a review of the genomic testing and biomarker landscape as well as the rapidly developing treatment armamentarium, with an emphasis on the potential impact of these newer therapies.